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During 2007–2009, we tested serum samples from 
2,004 pregnant women living in an area of high Q fever 
incidence in the Netherlands. Results confi rmed that 
presence of antibodies against Coxiella burnetii is related 
to proximity to infected dairy goat farms. Pregnant women 
and patients with certain cardiovascular conditions should 
avoid these farms.
Dairy goat farms were implicated in the large Q fever epidemic (>3,500 human cases) in the Netherlands 
during 2007–2009 (1,2). However, most human infections 
remain asymptomatic or appear as a self-limiting febrile 
illness and are therefore not reported. Seroprevalence 
studies are needed to discover the true infection pressure in 
the population. We aimed to establish whether the presence 
of antibodies to Coxiella burnetii, the etiologic agent of 
Q fever, is associated with physical proximity to infected 
small ruminant (dairy sheep and goat) farms.
The Study
Serum samples from pregnant women were obtained 
from laboratories located in the high-incidence Q fever 
area in the province of Noord-Brabant. The samples 
had been collected during June 20, 2007–May 26, 2009, 
during a screening program for syphilis, hepatitis B, and 
HIV infection, which was routinely offered to all pregnant 
women. Serum samples were analyzed by using an 
immunofl uorescence assay (Focus Diagnostics, Cypress, 
CA, USA) for detecting IgG and IgM against phases I and 
II of C. burnetii infection in a single dilution of 1:64. An 
IgG II titer >64 was considered indicative of past infection. 
Possible recent infection was defi ned as IgM II >64 
combined with either an IgG II or IgM I titer >64.
We included 10 adjacent municipalities (Figure 1) that 
had an incidence of Q fever notifi cations over the study 
period of 0.5–19.6 per 1,000 population and with clear 
seasonal peaks (Figure 2). Median age of the 2,004 women 
in the study was 30 years (interquartile range 27–33 years) 
with no signifi cant differences between the municipalities. 
Seroprevalence for past infection was 9.0% (181/2,004), 
ranging from 0% to 21% between the 10 municipalities 
(Table 1). In 57 (31%) of 181 women, IgM II titer was >64. 
Only 2 women had an IgM II titer >64 and IgM I titer >64 
without an IgG II titer >64. Seroprevalence for possible 
recent infection was therefore 2.9% (59/2,004), with a 
range of 0%–10% between the 10 municipalities.
For each pregnant woman, we calculated the distance 
from her home address to the closest farms in the 
following 3 categories: 1) dairy goat or dairy sheep farm 
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Figure 1. Location of the 10 municipalities studied in southern 
area of the Netherlands, 2007–2009, with residence and serologic 
results for 2,004 pregnant women, sites of small ruminant farms 
with infected animals, and address density. Three of the 20 farms 
included in the analysis are not visible. 
Goat Farms and C. burnetii Seroprevalence 
where clinical Q fever (i.e., abortion waves) occurred 
during 2005–2009 (data from Animal Health Service) 
(8 farms [all goat farms] were identifi ed in this way, of 
which 6 were located within or just outside of the study 
area) (Figure 1); 2) dairy goat or dairy sheep farms at 
which bulk tank milk tested positive for C. burnetii 
antibodies in the mandatory bulk tank milk monitoring 
program in 2009 (data from Food and Consumer Product 
Safety Authority; 12 goat farms were identifi ed); and 
3) a farm with >100 goats or sheep, irrespective of the 
infection status and production type (milk or meat) of the 
farm (data from the Ministry of Agriculture, Nature and 
Food Quality). Details of category 1 and category 2 farms 
are provided in the online Appendix Table (wwwnc.cdc.
gov/EID/article/17/12/11-0738-TA1.htm).
Univariate regression analysis showed that pregnant 
women living <2 km from a farm that had experienced 
clinical Q fever had a higher risk of testing positive for 
antibodies to C. burnetii than those living >5 km away 
(odds ratio 2.63, 95% confi dence interval 1.33–5.20 for IgG 
II titer >64 and odds ratio 6.58, 95% confi dence interval 
2.78–15.55 for possible recent infection). The increased risk 
for farms that had positive test results during monitoring of 
bulk tank milk was not signifi cant. No increased risk was 
found for women who lived close to any farm with >100 
animals. However, 98% of the population in the study area 
live within 5 km of such farms. In multivariate logistic 
regression analyses, taking into account address density of 
the neighborhood and other relevant variables, living <2 
km from a farm with clinical Q fever remained a strong risk 
factor (Table 2).
Conclusions
The presence of antibodies against C. burnetii, 
especially levels suggesting recent infection, is associated 
with living near a farm with infected dairy goats. This 
fi nding applied only to farms where animals had clinical Q 
fever and not for farms where tests of bulk tank milk were 
positive. A study in 2008 showed that persons who lived 
near (<2 km) an infected dairy goat farm had a much higher 
risk for Q fever than did persons who lived further away 
(>5 km) (3). However, these results were based on notifi ed 
cases, i.e., patients with clinical signs. Because the link to 
goat farming has received substantial attention in the public 
media, persons living close to goat farms may have sought 
medical care for suspected Q fever more rapidly than those 
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Serologic profile, no. (%) women 
IgG II titer >64 Possible recent infection*
Lith 6,667 42 9 (21.4) 4 (9.5) 
Oss 77,097 702 57 (8.1) 22 (3.1) 
Maasdonk 11,260 38 5 (13.2) 0 
Bernheze 29,615 291 30 (10.3) 15 (5.2) 
Landerd 14,805 72 6 (8.3) 4 (5.6) 
Uden 40,360 380 32 (8.4) 8 (2.1) 
Veghel 37,125 355 37 (10.4) 6 (1.7) 
Boekel 9,692 84 5 (6.0) 0 
Schijndel 22,889 18 0 0 
Sint-Oedenrode 17,427 22 0 0 
Total 266,937 2,004 181 (9.0) 59 (2.9) 
*IgM titer to phase II antigen >64 combined with either an IgG II or IgM I titer >64. 
Figure 2. Q fever notifi cations by month 
of onset of illness in 10 municipalities 
in southern area of the Netherlands, 
2007–2009.
who lived distantly from goat farms. Our population-based 
serologic study had a control group of seronegative women 
and identifi ed asymptomatic infections. Combined, both 
studies provide evidence that living near dairy goat farms 
that experience abortion waves increases the risk in humans 
for symptomatic and asymptomatic C. burnetii infection.
A limitation of this study is that the exact infectious 
periods for each of the 20 farms in the study are unknown. 
Mandatory systematic monitoring of bulk tank milk only 
started in October 2009. However, for 17 of the 20 farms 
identifi ed in the distance calculations in the present study, 
bulk tank milk testing results from 2008 were available 
from the records of the Animal Health Service. When an 
ELISA was performed, animals at 13 of the 17 farms tested 
positive for C. burnetii antibodies (online Appendix Table). 
Furthermore, for 15 of the 17 farms, bulk tank milk tested 
positive by PCR in 2008. The assumption that persons 
became infected where they lived, although infection 
might have occurred elsewhere, might have weakened 
the association between house location and infected 
farms because of nondifferential misclassifi cation. We 
did not account for circumstances that may play a role in 
transmission from farm to humans, such as wind, vegetation 
patterns, and soil conditions around infected farms (4). We 
assume that the effect of the voluntary vaccination program 
of small ruminants in 2008 had only limited effects on the 
study. Culling of pregnant animals on infected farms did 
not affect the results of the study because that began in 
December 2009.
We found an overall prevalence of IgG II antibodies of 
9.0%. In comparison, during 2006–2007, a seroprevalence 
of 2.4% was found in a nationwide seroprevalence survey 
in the Netherlands, just before the fi rst major outbreak (5). 
The present Q fever epidemic peaked right after the last 
data were collected for the present study. In the second 
half of 2009, seroprevalence for blood donors in the high-
incidence area was estimated at 12.2% (6). The fi ndings 
of the different seroprevalence studies are consistent with 
the view that Q fever newly emerged in the Netherlands, 
peaking in 2009, and that a high infection pressure 
has resulted in increased seroprevalence in the general 
population, including in pregnant women.
Whether infection during pregnancy is associated 
with adverse pregnancy outcomes remains uncertain. The 
international literature suggests this conclusion, but an 
analysis based on 1,174 of the 2,004 women included in the 
present study showed no evidence of adverse pregnancy 
outcome among women with antibodies to C. burnetii 
(7–9). Despite uncertainties surrounding the clinical 
signifi cance of asymptomatic seropositivity, this study 
supports the recommendation that pregnant women and 
persons at risk for chronic Q fever, such as patients with 
certain cardiovascular conditions, should avoid visiting 
infected farms.
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Whom are they affecting?
Why are they emerging now?
What can we do to prevent and 
control them?
Hyatt Regency Atlanta
265 Peachtree Street NE
Atlanta, Georgia, USA 30303
The International Conference on Emerging Infectious Dis-
eases was fi rst convened in 1998; ICEID 2012 marks its 
eighth occurence. The conference brings together public 
health professionals to encourage the exchange of scien-
tifi c and public health information on global emerging in-
fectious disease issues. The program will include plenary 
and panel sessions with invited speakers as well as oral 
and poster presentations on emerging infections. Major 
topics to be included are current work on surveillance, epi-
demiology, research, communication and training, bioter-
rorism, and prevention and control of emerging infectious 
diseases, both in the United States and abroad. 
